Literature DB >> 28531080

Validation of the Scale of Functioning in Older Outpatients With Schizophrenia.

Mark H Rapaport1, James Bazzetta1, Lou Ann McAdams1, Thomas Patterson1, Dilip V Jeste1.   

Abstract

The authors investigated the reliability and validity of the Scale of Functioning (SOF), a 15-item scale, in 78 middle-aged and elderly outpatients with schizophrenia. The SOF score had both high internal consistency and high interrater reliability and significantly discriminated between these patients and 45 normal comparison subjects. SOF scores correlated significantly with scores on several psychopathology rating scales as well as a number of existing instruments assessing cognitive or functional ability. Principal-components analysis using different scales of functional ability, psychopathology, and global cognitive performance and treated by orthogonal rotation revealed two domains of functioning, one of which was defined by the SOF along with scales for activities of daily living, negative symptoms, and cognitive impairment. The other domain was defined by scales for quality of well-being, social adjustment, and positive and depressive symptoms. Results support the construct validity of the SOF in late-life schizophrenia.
Copyright © 1996 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID: 28531080     DOI: 10.1097/00019442-199622430-00005

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  8 in total

1.  Combination Antipsychotic Therapies: An Analysis From a Longitudinal Pragmatic Trial.

Authors:  Adriana Foster; Peter Buckley; John Lauriello; Stephen Looney; Nina Schooler
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153

2.  Disentangling early sensory information processing deficits in schizophrenia.

Authors:  Anthony J Rissling; David L Braff; Neal R Swerdlow; Gerhard Hellemann; Yuri Rassovsky; Joyce Sprock; Marlena Pela; Gregory A Light
Journal:  Clin Neurophysiol       Date:  2012-05-18       Impact factor: 3.708

Review 3.  Consortium on the Genetics of Schizophrenia (COGS) assessment of endophenotypes for schizophrenia: an introduction to this Special Issue of Schizophrenia Research.

Authors:  Neal R Swerdlow; Raquel E Gur; David L Braff
Journal:  Schizophr Res       Date:  2014-10-24       Impact factor: 4.939

4.  Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.

Authors:  Gregory A Light; Neal R Swerdlow; Michael L Thomas; Monica E Calkins; Michael F Green; Tiffany A Greenwood; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Keith H Nuechterlein; Marlena Pela; Allen D Radant; Larry J Seidman; Richard F Sharp; Larry J Siever; Jeremy M Silverman; Joyce Sprock; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; David L Braff; Bruce I Turetsky
Journal:  Schizophr Res       Date:  2014-10-23       Impact factor: 4.939

5.  Hierarchical Pathways from Sensory Processing to Cognitive, Clinical, and Functional Impairments in Schizophrenia.

Authors:  Daisuke Koshiyama; Michael L Thomas; Makoto Miyakoshi; Yash B Joshi; Juan L Molina; Kumiko Tanaka-Koshiyama; Joyce Sprock; David L Braff; Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

6.  Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia.

Authors:  Gregory A Light; Neal R Swerdlow; Anthony J Rissling; Allen Radant; Catherine A Sugar; Joyce Sprock; Marlena Pela; Mark A Geyer; David L Braff
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

7.  Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method.

Authors:  M Randau; B Oranje; M Miyakoshi; S Makeig; B Fagerlund; B Glenthøj; N Bak
Journal:  Neuroimage Clin       Date:  2019-03-12       Impact factor: 4.881

Review 8.  Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits.

Authors:  David R Goldsmith; Mark Hyman Rapaport
Journal:  Front Psychiatry       Date:  2020-02-20       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.